Tumban E - Search Results

1

Replacement of conserved or variable sequences of the mosquito-borne dengue virus 3' UTR with homologous sequences from Modoc virus does not change infectivity for mosquitoes.

Tumban E, Maes NE, Schirtzinger EE, Young KI, Hanson CT, Whitehead SS, Hanley KA. Tumban E, et al. J Gen Virol. 2013 Apr;94(Pt 4):783-788. doi: 10.1099/vir.0.046664-0. Epub 2012 Dec 19. J Gen Virol. 2013. PMID: 23255623 Free PMC article.

2

Secondary structure of dengue virus type 4 3' untranslated region: impact of deletion and substitution mutations.

Romero TA, Tumban E, Jun J, Lott WB, Hanley KA. Romero TA, et al. Among authors: tumban e. J Gen Virol. 2006 Nov;87(Pt 11):3291-3296. doi: 10.1099/vir.0.82182-0. J Gen Virol. 2006. PMID: 17030863

3

Replacement of the 3' untranslated variable region of mosquito-borne dengue virus with that of tick-borne Langat virus does not alter vector specificity.

Tumban E, Mitzel DN, Maes NE, Hanson CT, Whitehead SS, Hanley KA. Tumban E, et al. J Gen Virol. 2011 Apr;92(Pt 4):841-8. doi: 10.1099/vir.0.026997-0. Epub 2011 Jan 7. J Gen Virol. 2011. PMID: 21216984 Free PMC article.

4

Zika Virus on a Spreading Spree: what we now know that was unknown in the 1950's.

Basu R, Tumban E. Basu R, et al. Among authors: tumban e. Virol J. 2016 Oct 6;13(1):165. doi: 10.1186/s12985-016-0623-2. Virol J. 2016. PMID: 27716242 Free PMC article. Review.

5

A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2.

Tumban E, Peabody J, Peabody DS, Chackerian B. Tumban E, et al. PLoS One. 2011;6(8):e23310. doi: 10.1371/journal.pone.0023310. Epub 2011 Aug 17. PLoS One. 2011. PMID: 21858066 Free PMC article.

6

VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus.

Tumban E, Peabody J, Tyler M, Peabody DS, Chackerian B. Tumban E, et al. PLoS One. 2012;7(11):e49751. doi: 10.1371/journal.pone.0049751. Epub 2012 Nov 19. PLoS One. 2012. PMID: 23185426 Free PMC article.

7

Second-generation prophylactic HPV vaccines: successes and challenges.

Tyler M, Tumban E, Chackerian B. Tyler M, et al. Among authors: tumban e. Expert Rev Vaccines. 2014 Feb;13(2):247-55. doi: 10.1586/14760584.2014.865523. Epub 2013 Dec 18. Expert Rev Vaccines. 2014. PMID: 24350614 Free PMC article. Review.

8

Immunization with a consensus epitope from human papillomavirus L2 induces antibodies that are broadly neutralizing.

Tyler M, Tumban E, Dziduszko A, Ozbun MA, Peabody DS, Chackerian B. Tyler M, et al. Among authors: tumban e. Vaccine. 2014 Jul 23;32(34):4267-74. doi: 10.1016/j.vaccine.2014.06.054. Epub 2014 Jun 21. Vaccine. 2014. PMID: 24962748 Free PMC article.

9

The use of hybrid virus-like particles to enhance the immunogenicity of a broadly protective HPV vaccine.

Tyler M, Tumban E, Peabody DS, Chackerian B. Tyler M, et al. Among authors: tumban e. Biotechnol Bioeng. 2014 Dec;111(12):2398-406. doi: 10.1002/bit.25311. Epub 2014 Jul 31. Biotechnol Bioeng. 2014. PMID: 24917327 Free PMC article.

10

Aerosol delivery of virus-like particles to the genital tract induces local and systemic antibody responses.

Hunter Z, Tumban E, Dziduszko A, Chackerian B. Hunter Z, et al. Among authors: tumban e. Vaccine. 2011 Jun 20;29(28):4584-92. doi: 10.1016/j.vaccine.2011.04.051. Epub 2011 May 5. Vaccine. 2011. PMID: 21549786 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters